对ABCG1的上调与急性淋巴细胞白血病细胞中甲铁抗性有关
Yao Chen1, Houshun Fang1, Huiying Sun1
1Pediatric Translational Medicine Institute, Key Laboratory of Pediatric Hematology and Oncology Ministry of Health, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Frontiers in pharmacology
|January 23, 2024
概括
儿童急性淋巴细胞白血病 (ALL) 中甲抗性与ABCG1转运体表达的增加有关. 抑制ABCG1可能会恢复对甲状腺素的敏感性,为ALL提供新的治疗策略.
科学领域:
- 血液学恶性瘤是什么
- 儿科瘤学 儿科瘤学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 甲托雷克萨特 (MTX) 是儿童急性淋巴细胞白血病 (ALL) 的基石治疗方法.
- 对MTX的临床耐药性在实现完全缓解方面存在重大挑战.
- 了解MTX耐药性的机制对于开发有效疗法至关重要.
研究的目的:
- 调查在ALL中MTX耐药性背后的分子机制.
- 确定潜在的治疗点,以克服ALL中的MTX耐药性.
主要方法:
- 从父母的Reh细胞中建立了一个抗MTX的ALL细胞系 (Reh-MTXR).
- 使用RNA测序 (RNA-seq) 来比较基因表达特征.
- 对ATP结合盒载体G1 (ABCG1) 进行了基因淘汰和过度表达研究.
- 评估了MTX流量,细胞内MTX代谢物积累和药物敏感性.
- 研究了ABCG1抑制剂 (本扎米尔) 对MTX耐药性的影响.
主要成果:
- 与Reh细胞相比,Reh-MTXR细胞对MTX表现出显著的耐药性.
- RNA-seq显示了ABCG1在Reh-MTXR细胞中的明显上调.
- 在ABCG1的淘汰下,MTX的阻力被逆转,而其过度表达则会产生阻力.
- 增加的ABCG1表达加速了MTX流量,并减少了MTX多重化.
- 西使MTX耐药细胞对MTX治疗产生敏感性.
结论:
- 对ABCG1的升级是驱动ALL中MTX耐药性的关键机制.
- ABCG1促进MTX流量,降低其治疗疗效.
- 针对ABCG1使用士米尔等抑制剂是治疗MTX耐药ALL的一个有前途的策略.
相关概念视频
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K